~~<i id='464944E961'><strike id='464944E961'><tt id='464944E961'><pre id='464944E961'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：knowledge 2025-09-28 09:20:24 Page View：4698

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Testing for cancer recurrence creates a new limbo for patients
Next article： In Memoriam: Notable people who died in 2023

comprehensive

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

DarronCummings/APTheFoodandDrugAdministrationonThursdayapprovedanEliLillydrugthattakesanewapproachto

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Cord blood banking comes at a high cost to babies

Ifhersocialmediaaccountsareanyindication,model,cookbookauthor,televisionpersonality,andentrepreneurC